- Introducing the AVIEW lineup specialized in simultaneous diagnosis and analysis of thoracic diseases
- Participating in HIMSS on March 3rd and completing HIPAA certification
HUNTINGTON BEACH, Calif. and SEOUL, South Korea, Feb. 21, 2025 -- Coreline Soft will demonstrate its cutting-edge AI-based lung and thoracic imaging solution lineup at the Society of Thoracic Radiology 2025 (STR) on March 1st. STR is an international academic event where global thoracic radiology experts share the latest research results and future technology trends. This year, AI technology related to lung and thoracic diseases, along with combined diagnostics trends, is expected to attract significant attention. The conference will be held at the Hyatt Huntington Beach, California, from March 1 to 5, 2025.
At the STR 2025 event, Coreline Soft will showcase AI-based thoracic diagnostic solutions centered around AVIEW LCS, which was recently recognized for its excellent accuracy and rapid result derivation capability in first-reading performance published in the European Journal of Cancer. The lineup also includes AVIEW Lung Texture, a fully automated and quantitative analysis software for interstitial lung disease (ILD) specialized in thoracic disease diagnosis, and AVIEW COPD, an automatic analysis software for chronic obstructive pulmonary disease (COPD). Coreline Soft will also actively introduce its technology that supports companion tests and complex analyses.
"Last year, at several thoracic disease conferences held in the U.S., the method of quantitatively analyzing biomarkers such as COPD and ILD using AI technology to accurately predict treatment effects and prognosis garnered much attention," said James Lee, Head of Coreline North America. "In particular, as collaboration between pharmaceutical companies and AI software companies becomes more active, precise data analysis is emerging as a key value in the new drug development stage."
He continued, "This is a great opportunity for Coreline Soft to showcase its quantitative analysis capabilities, already recognized as AI lung disease diagnosis technology, at STR, one of the most influential academic events in the field of thoracic radiology. We will expand cooperation with medical platforms around the world, including the US market, to contribute to accurate companion tests and innovative comprehensive diagnosis."
Coreline Soft specializes in AI-based thoracic imaging diagnosis and supplies quantitative analysis solutions for major respiratory diseases such as lung cancer, COPD, and ILD to the global market.
Meanwhile, Coreline North America supplies products to major medical institutions, including the Temple Lung Center, and is expanding cooperation with leading institutions such as the Mount Sinai Respiratory Institute.
It also plans to participate in the 2025 HIMSS Global Health Conference & Exhibition (HIMSS), the world's largest medical IT exhibition, to be held in Las Vegas, USA, on March 3. HIMSS is the world's largest healthcare IT technology event, and Coreline Soft recently achieved compliance certification for both the US Health Insurance Portability and Accountability Act (HIPAA) and the European General Data Protection Regulation (GDPR).
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
